This study is looking at what happens when people with a type of heart failure called Heart Failure With Preserved Ejection Fraction (HFpEF) stop taking their beta-blocker medication. Researchers want to see if stopping beta-blockers changes how you feel and your quality of life. They will measure this using a questionnaire called the KCCQ-23 score. You might be able to join if you are between 50 and 80 years old, have stable HFpEF, and are currently taking a beta-blocker. The study aims to enroll 30 participants, but its current recruitment status is unclear.

Study design

This is a pilot study that will look at changes in 30 participants before and after stopping beta-blockers. It is an interventional study, meaning participants will receive a specific intervention.

What's involved

You would have two study visits over a period of about 4 weeks. The first visit is a standard clinic visit, and the second involves questionnaires and a limited echocardiogram (a heart ultrasound).

Compensation

Not stated in the trial record.

Follow-up

There is no long-term follow-up beyond the second visit, which occurs 4 weeks after stopping beta-blockers.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.